Glenn C.
About Glenn C.
Glenn D. Crater: Chief Medical Officer at Inversago
Glenn D. Crater currently serves as the Chief Medical Officer at Inversago. With over two decades of experience in the fields of clinical development and medical affairs, he plays a crucial role in advancing the company's medical and clinical strategies. His extensive professional background includes significant contributions to various aspects of drug development, particularly in rare diseases. Crater has a history of leading successful programs that culminated in regulatory approvals such as NDA, MAA, and 510K.
Glenn D. Crater Education and Medical Expertise
Glenn D. Crater obtained his MD degree from the University of Tennessee. He is board certified in Internal Medicine and pulmonary diseases. His educational background and certifications have provided a strong foundation for his career in clinical development and medical affairs. Crater has applied his medical expertise in various executive roles, contributing to the successful development and approval of several prominent pharmaceutical products.
Glenn D. Crater Professional Background
Before joining Inversago, Glenn D. Crater held executive positions at Theravance Biopharma, Aerocrine, and GSK. His roles in these organizations involved leadership in clinical development and medical affairs, significantly impacting their drug development pipelines. His leadership in these companies was instrumental in advancing multiple programs leading to regulatory submissions and approvals.
Glenn D. Crater Drug Development Achievements
Glenn D. Crater has led multiple drug development programs resulting in key regulatory approvals, including NDA, MAA, and 510K. Notable products developed under his guidance include ADVAIR, ANORO, NIOX VERO, and YUPELRI. Crater's work has contributed to significant advancements in the pharmaceutical industry, particularly in the treatment of pulmonary diseases and other medical conditions.